Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| DENDREON CORP | 411,000 | reported | 16 Jun 2004 | tx 9+168,772−49,706 |
| Anthera Pharmaceuticals Inc | 84,705 | reported | 05 Jan 2018 | tx 23+848,360−87,827 |
| Sarepta Therapeutics, Inc. | 60,000 | reported | 31 Mar 2009 | tx 1+60,000 |
| XCYTE THERAPIES INC | 39,415 | reported | 30 Jun 2023 | tx 21+548,914 |
| PROTHENA CORP PUBLIC LTD CO | 2,000 | reported | 14 Jul 2021 | tx 84+355,120−215,800 |
| SGX PHARMACEUTICALS, INC. | 0 | reported | 20 Aug 2008 | tx 13+94,578−211,321 |
| BIO-TECHNE Corp | 0 | reported | 31 Oct 2003 | tx 7+15,000−20,000 |
| Oncothyreon Inc. | 0 | reported | 09 Mar 2018 | tx 65+664,839−248,695 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 30 Jun 2023 | GRANT_AWARD | XCYTE THERAPIES INC | 21,219 | 0.00 USD | |
| 30 Jun 2023 | GRANT_AWARD | XCYTE THERAPIES INC | 42,438 | 0.00 USD | deriv |
| 14 Jun 2022 | GRANT_AWARD | XCYTE THERAPIES INC | 15,822 | 0.00 USD | |
| 14 Jun 2022 | GRANT_AWARD | XCYTE THERAPIES INC | 31,645 | 0.00 USD | deriv |
| 14 Jul 2021 | SALE | PROTHENA CORP PUBLIC LTD CO | 2,000 | 56.13 USD | |
| 14 Jul 2021 | EXERCISE | PROTHENA CORP PUBLIC LTD CO | 11,108 | 11.33 USD | |
| 14 Jul 2021 | SALE | PROTHENA CORP PUBLIC LTD CO | 9,108 | 55.31 USD | |
| 14 Jul 2021 | EXERCISE | PROTHENA CORP PUBLIC LTD CO | 11,108 | 0.00 USD | deriv |
| 12 Jul 2021 | SALE | PROTHENA CORP PUBLIC LTD CO | 700 | 57.85 USD | |
| 12 Jul 2021 | SALE | PROTHENA CORP PUBLIC LTD CO | 2,475 | 55.95 USD | |
| 12 Jul 2021 | SALE | PROTHENA CORP PUBLIC LTD CO | 5,886 | 54.55 USD | |
| 12 Jul 2021 | SALE | PROTHENA CORP PUBLIC LTD CO | 6,228 | 53.84 USD | |
| 12 Jul 2021 | EXERCISE | PROTHENA CORP PUBLIC LTD CO | 17,500 | 9.23 USD | |
| 12 Jul 2021 | SALE | PROTHENA CORP PUBLIC LTD CO | 177 | 61.25 USD | |
| 12 Jul 2021 | SALE | PROTHENA CORP PUBLIC LTD CO | 300 | 59.45 USD | |
| 12 Jul 2021 | SALE | PROTHENA CORP PUBLIC LTD CO | 800 | 58.66 USD | |
| 12 Jul 2021 | SALE | PROTHENA CORP PUBLIC LTD CO | 1,634 | 56.88 USD | |
| 12 Jul 2021 | SALE | PROTHENA CORP PUBLIC LTD CO | 500 | 58.21 USD | |
| 12 Jul 2021 | SALE | PROTHENA CORP PUBLIC LTD CO | 600 | 59.25 USD | |
| 12 Jul 2021 | SALE | PROTHENA CORP PUBLIC LTD CO | 177 | 61.25 USD | |
| 12 Jul 2021 | EXERCISE | PROTHENA CORP PUBLIC LTD CO | 6,392 | 11.33 USD | |
| 12 Jul 2021 | SALE | PROTHENA CORP PUBLIC LTD CO | 2,315 | 55.26 USD | |
| 12 Jul 2021 | SALE | PROTHENA CORP PUBLIC LTD CO | 2,100 | 56.56 USD | |
| 12 Jul 2021 | EXERCISE | PROTHENA CORP PUBLIC LTD CO | 17,500 | 0.00 USD | deriv |
| 12 Jul 2021 | EXERCISE | PROTHENA CORP PUBLIC LTD CO | 6,392 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 30 Jan 2017.